Effectiveness and Safety of Intradermal Tranexamic Acid Injection as An Adjunctive Treatment for Melasma in Skin Type IV - V

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2022
A double-blind, randomized, split-face controlled trial of 34 female patients with melasma was conducted. All subject were randomized to receive either intradermal tranexamic acid or placebo injection on the right or the left side of their face.
Epistemonikos ID: 2d018e7892e37de3d01e8c10cb74a2f81cec235c
First added on: Oct 02, 2023